InSpace Accelerated Rehabilitation Study

Launched by STRYKER ENDOSCOPY · Apr 7, 2022

Keywords

ClinConnect Summary

The InSpace Accelerated Rehabilitation Study is a research trial that aims to compare two different rehabilitation programs for patients with severe rotator cuff tears, specifically those that are large and difficult to repair. This study is focused on individuals aged 65 and older who have been diagnosed with a full thickness rotator cuff tear that is at least 5 centimeters in size and involves two or more tendons. To be eligible, participants must have tried non-surgical treatments without success for at least three months and have ongoing pain.

If you choose to participate, you will undergo an arthroscopic procedure to treat your shoulder and then follow one of the two rehabilitation programs using the InSpace device. The trial is currently recruiting participants, and those who join will need to attend follow-up visits to monitor their progress. It's important to note that certain health conditions or prior surgeries may prevent someone from qualifying for the study. The ultimate goal of this trial is to improve recovery options for patients with challenging shoulder injuries, helping them regain function and reduce pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Subjects MUST meet ALL the following criteria to be included in the study:
• • The subject has signed the IRB approved Informed Consent Form (ICF) specific to this study prior to enrollment
• • Is male or female ≥ sixty-five (65) years of age
• * Positive diagnostic imaging by MRI within 9 months of enrollment of the index shoulder indicating a full thickness MRCT:
• • Measuring ≥ 5 cm in diameter
• • Involving ≥ two tendons
• • Functional deltoid muscle and preserved passive range of motion on physical examination
• • Documented VAS score \> 30 mm pain
• * Failed non-operative treatment of at least 3 months from the initial treatment to include one or more of the following:
• • Oral analgesics
• • Anti-inflammatory medication (e.g., ibuprofen, naproxen)
• • Corticosteroid injection(s)
• • Physical therapy
• • Activity modification
• • Rest (sling used)
• • Must be able to read and understand the approved Informed Consent Form (written and oral)
• • Must be in general good health (as determined by the Investigator) based on screening assessments and medical history
• • Must be independent, ambulatory, and can comply with all post-operative evaluations, visits, and electronic database collection
• • Intra-operative Inclusion Criteria
• Subjects MUST meet the following criteria to be randomized in the study:
• • Full thickness tear
• • Tear size ≥ 5 cm in diameter
• • Tear involving ≥ two tendons
• Exclusion Criteria:
• Subjects will be excluded from the study, if they meet ANY of the following individual exclusion criteria:
• • Known allergy to the device material (copolymer of PLA (poly (lactic acid) and -ε-caprolactone)
• * Evidence of the following conditions:
• • Severe gleno-humeral or acromio-humeral arthritis
• • Full thickness cartilage loss as seen on MRI
• • History within the past 5 years of anterior or posterior shoulder subluxation or dislocation as determined by history, examination, or radiographic findings
• • Pre-existing deltoid defect or deltoid palsy
• • Major joint trauma, infection, or necrosis
• • Partial thickness tears of the supraspinatus
• • Fully reparable rotator cuff tear \[Tear of less than 5 cm in diameter (or \< 4 cm2) with retractable tendon that can be fully repaired\]
• • Known neurovascular compromise
• • Complete deltoid muscle palsy
• • Traumatic muscle tears of the pectoralis or deltoid
• * The subject requires concomitant:
• • Subscapularis repair
• • Labral repair of any type
• • Biceps tenodesis
• • Previous surgery of the index shoulder in the past 1 year, excluding diagnostic arthroscopy
• • The subject's condition is bilateral and rotator cuff repair is scheduled or to be scheduled over the course of this study for the contra lateral shoulder
• • Major medical condition that could affect quality of life and influence the results of the study (e.g., rheumatoid arthritis)
• • The subject has documented evidence of a history (e.g., liver testing) of drug/alcohol abuse within 12 months of enrollment
• • The subject's condition represents a worker's compensation case
• • The subject is currently involved in a health-related litigation procedure
• • Females of child-bearing potential who are pregnant or plan to become pregnant.
• • Concurrent participation in an investigational clinical study one month prior to enrollment or during the entire study period
• • The subject is physically or mentally compromised (e.g., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extent that the Investigator judges the subject to be unable or unlikely to remain compliant to follow-up
• • The subject is receiving prescription narcotic pain medication for conditions unrelated to the index shoulder condition
• • The subject currently has an acute infection in the area surrounding the surgical site.
• • Baseline WORC score less than 420
• Intra-operative Exclusion Criteria:
• Subjects will not be randomized and will be terminated from the study if they meet ANY of the following individual intra-operative exclusion criteria:
• * Rotator cuff is/presents with:
• • Fully reparable with adequate tissue and muscle quality (equivalent to Goutallier stage 1 or 2)
• • Partial thickness tear of the supraspinatus
• • Evidence of significant osteoarthritis
• * The subject requires concomitant:
• • Subscapularis repair
• • Labral repair of any type
• • Biceps tenodesis
• • Coracoacromial ligament functional deficiency or shoulder instability is identified